Healthcare
European drugmakers say they are 'losing ground' to US and Chinese rivals
Some of continent's biggest pharma firms write to national leaders calling for action to safeguard their futures. Some of Europe's biggest pharmaceutical compa…
Keyword
Drugmaker
No market stories in the last 7 days. The latest coverage is below.
- 7-day mood
- —Not enough data
- Stories, 7 days
- 0
- Last 24 hours
- 0no baseline yet
- Sources
- 13in the latest 30
Mood and coverage · last 7 days
Market chart- Drugmaker · 6-hour average
- Hourly reading
- Stories per hour
No scored stories in the last 7 days.
View as table
| Day | Mood | Stories |
|---|---|---|
| Sat, Oct 10 | — | 0 |
| Fri, Oct 9 | — | 0 |
| Thu, Oct 8 | — | 0 |
| Wed, Oct 7 | — | 0 |
| Tue, Oct 6 | — | 0 |
| Mon, Oct 5 | — | 0 |
| Sun, Oct 4 | — | 0 |
| Sat, Oct 3 | — | 0 |
Latest on Drugmaker
Newest firstHealthcare
Novo shares slide as drugmaker lays out post-Wegovy growth strategy
The Danish company seeks to convince investors it can compete in an increasingly crowded field it helped pioneer.
Healthcare
Novo Nordisk rebrands to 'Novo,' unveils corporate changes as it fights for obesity market share
The Danish drugmaker called the changes the beginning of a new chapter for the company, which faces stiff competition from Eli Lilly.
Healthcare
Trump reportedly plans to announce new drug pricing deals with nearly a dozen drugmakers
The string of deals builds on the Trump administration's push to link the nation's drug prices to cheaper ones abroad.
Healthcare
AstraZeneca boss urges western drugmakers to move at 'Chinese speed'
Europe and US risk being outpaced on innovation, as happened in the car industry, warns Pascal SoriotAstraZeneca must operate at "Chinese speed" to ensure it d…
Healthcare
Major drugmaker loses $27 billion in market value after failed trial
Two companies announced on Thursday that the heart disease drug they had been developing failed its Phase III trial.
Healthcare
Drugmakers race to find a place in the next wave of obesity drugs
Drugmakers are betting they can crack into the obesity drug market that Novo Nordisk and Eli Lilly currently dominate.
Healthcare
Nuvalent shares surge 39% after UK's GSK agrees to buy the cancer drugmaker for $10.6 billion
The deal comes at a time of biotech dealmaking frenzy, driven by looming patent cliffs, newly buoyant public markets and drugmakers' race to bolster pipelines.
Healthcare
Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals
Novo Nordisk CEO Mike Doustdar says the Ozempic and Wegovy maker is looking for deals more than ever before.
Healthcare
American Factories Lag in Adopting A.I. This Drugmaker Is an Exception.
A Bristol Myers Squibb plant that makes cancer drugs was the only manufacturer in the U.S. recognized for innovation by the World Economic Forum this year.
Healthcare
Trump's drugmaker deals may save economy $529B over 10 years, White House says
President Donald Trump's deals with drugmakers requiring many of their U.S. prescription prices to drop could save the economy $529 billion over the next decade
Healthcare
Drugmaker AbbVie chooses North Carolina for $1.4B manufacturing campus
The 185-acre site will be the company's largest single investment to date, with a focus on small-volume parenteral products like vials and prefilled syringes.
Healthcare
Drugmaker Asks SCOTUS To Let Mail-Order Abortions Continue Despite Lower Court Order
A pharmaceutical company that makes the chemical abortion pill mifepristone urged the Supreme Court on Saturday to temporarily halt a federal appeals court's F…
Healthcare
Drugmaker asks Supreme Court to restore abortion pill access by mail
The U.S. Court of Appeals for the 5th Circuit ruled that the commonly used abortion drug mifepristone can only be picked up in-person.
Healthcare
Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal
To fuel its global ambitions, Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.…
Healthcare
Roche CEO laments Swiss franc strength as drugmaker doubles down on U.S. investment
Currency effects weighed on the Swiss drugmaker's first-quarter earnings
Healthcare
Belgian drugmaker UCB to invest $2B in suburban Atlanta plant, adding 330 jobs
Belgian pharmaceutical maker UCB says it will build a $2 billion drug manufacturing plant near Atlanta
Healthcare
US weight loss drugmakers slash prices in fight to win customers
Weight-loss drug prices are falling in the US - but can the example be repeated?
Healthcare
Novo Nordisk's stock tumbles as drugmaker lays out case for declining sales in 2026
The maker of Ozempic and Wegovy blamed pricing pressures and competition for its downbeat outlook.
Healthcare
Drugmakers Roche and Sanofi talk up their pipelines, as earnings fail to excite
The drugmaker's full-year results didn't seem to move the needle for investors who are instead focused on future growth prospects and innovation
Healthcare
What obesity drugmakers see next in the market: More pills, easier access and drug combinations
CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare Conference in San Francisco.
Healthcare
Drugmakers to raise US prices on at least 350 medicines despite pressure from Trump
Drugmakers plan to raise US prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibra…
Healthcare
Trump reaches deal with 9 major drugmakers to lower prices
Nine drug manufacturers will offer their drugs to Medicaid recipients at most-favored-nation discounts in exchange for tariff exemptions.
Healthcare
Trump admin strikes zero tariff pharmaceutical deal with Britain - a move welcomed by drugmakers
The United States and Britain announced a deal on Monday to secure zero tariffs on British pharmaceutical products and medical technology in return for Britain…
Healthcare
Is GLP-1 the new AI? Drugmaker Eli Lilly briefly joins the $1 trillion market-cap club.
Eli Lilly on Friday briefly crossed the $1 trillion market-cap threshold, the first drugmaker to ever reach that milestone.
Healthcare
Metsera says Novo Nordisk's new up to $10 billion bid for obesity drugmaker is 'superior' to revised Pfizer offer
The clash reflects the shifting landscape for weight loss and diabetes drugs, with Novo Nordisk trailing Eli Lilly as companies like Pfizer race to break in.
Healthcare
Pfizer sues to stop rival bid for drugmaker Metsera by Denmark's Novo Nordisk
Pfizer is suing over some unsolicited competition in its nearly $5 billion bid to buy the drugmaker Metsera
Healthcare
Trump rolls out his latest deal with a drugmaker. This one stems from his campaign promise to cover all IVF costs.
President Donald Trump on Thursday announced a deal with EMD Serono, a subsidiary of German drugmaker Merck KGaA, that aims to cut the out-of-pocket costs for…
Healthcare
Genentech to sell flu pill directly to some consumers at a discount as Trump pressures drugmakers
The program will sell Xofluza through three pharmacies with a $50 cash pay option, which is 70% lower than the pill's current list price before insurance.
Healthcare
AstraZeneca to become latest drugmaker to strike deal with Trump. Its stock is down but outperforming the market.
AstraZeneca looks poised to announce a deal with U.S. President Donald Trump that's focused on lowering drug prices, in a move that would see the British drugm…
